𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?

✍ Scribed by Øystein Bruserud; Karl Johan Tronstad; Emmet McCormack; Bjørn Tore Gjertsen


Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
256 KB
Volume
55
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Capping of peripheral blood lymphocyte C
✍ Bobby J. Gormus; Michael L. Basara; Martin M. Oken; Stephen H. Leech; Manuel E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 882 KB

## Abstract The data show that in chronic lymphocytic leukemia (CLL) there are elevated numbers of peripheral blood lymphocytes (PBL) capable of rosette formation (complement‐rosetting lymphocytes, CRL) with bacteria (B)‐antibody‐(A)‐complement (C) (BAC) complexes. In most of the CLL patients studi

Chronic lymphocytic leukemia in associat
✍ Gordon, Leo I. ;Hrushesky, William ;Oken, Martin M. ;Kay, Neil E. ;Rydell, Rober 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

The development of either histiocytic lymphoma or Hodgkin disease in association with pre-existing chronic lymphocytic leukemia has been described in the literature as a terminal event. We describe two patients in whom the diagnosis of a second malignant lymphoma was made during life and who achieve

Ror1, a cell surface receptor tyrosine k
✍ Amir H. DaneshManesh; Eva Mikaelsson; Mahmood Jeddi-Tehrani; Ali Ahmad Bayat; Ro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 205 KB

## Abstract Gene profiling studies of patients with chronic lymphocytic leukemia (CLL) has revealed increased expression of Ror1, a cell surface receptor tyrosine kinase. The aim of present study was to analyze gene and protein expression of Ror1 in CLL cells and normal blood leukocytes. Gene expre